Literature DB >> 8675214

Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes.

H Akoum1, A Tsicopoulos, H Vorng, B Wallaert, J P Dessaint, M Joseph, Q Hamid, A B Tonnel.   

Abstract

The mechanism by which specific immunotherapy exerts its beneficial effect remains unclear. In order to evaluate the influence of venom immunotherapy on the T-cell cytokine pattern of allergic reactions, we studied interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) mRNA expression of peripheral T lymphocytes from 12 patients undergoing rush venom desensitization, before treatment at Day 0 (D0), at Day 15 (D15) and Day 90 (D90) after treatment, and from seven controls. Antigen-specific T-cell proliferation was also determined. Cytokine mRNA expression was evaluated using in situ hybridization, 24 hr after culture of peripheral T cells with medium, venom, or an unrelated allergen. Allergen-induced T-cell proliferation decreased at D15 and D90 of rush immunotherapy (P < or = 0.02). In venom-stimulated cultures of the patient group, there was a decrease in IL-4 mRNA-positive cells at D15 and D90 (P < or = 0.001). Before desensitization, IFN-gamma mRNA expression was lower in patients than in controls and did not increase after in vitro allergen stimulation. In contrast, after immunotherapy, spontaneous IFN-gamma mRNA expression increased, but only at D90 (P < or = 0.001). The cytokine pattern observed at D90 after immunotherapy was similar to that observed in control subjects. In conclusion, venom immunotherapy induced an altered cytokine mRNA pattern in allergen-stimulated T cells which was dissociated from the early changes of allergen-induced T-cell responsiveness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675214      PMCID: PMC1384138          DOI: 10.1046/j.1365-2567.1996.506585.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  CD4+ and CD8+ T cells acquire specific lymphokine secretion potentials during thymic maturation.

Authors:  A Bendelac; R H Schwartz
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

2.  Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis.

Authors:  K Jujo; H Renz; J Abe; E W Gelfand; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

3.  Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease.

Authors:  S A Brod; D Benjamin; D A Hafler
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

4.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.

Authors:  E Maggi; P Parronchi; R Manetti; C Simonelli; M P Piccinni; F S Rugiu; M De Carli; M Ricci; S Romagnani
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

5.  Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.

Authors:  A Tsicopoulos; Q Hamid; V Varney; S Ying; R Moqbel; S R Durham; A B Kay
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

7.  Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols.

Authors:  J Birnbaum; D Charpin; D Vervloet
Journal:  Clin Exp Allergy       Date:  1993-03       Impact factor: 5.018

8.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production.

Authors:  P Parronchi; D Macchia; M P Piccinni; P Biswas; C Simonelli; E Maggi; M Ricci; A A Ansari; S Romagnani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

9.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.

Authors:  R Manetti; P Parronchi; M G Giudizi; M P Piccinni; E Maggi; G Trinchieri; S Romagnani
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

10.  Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.

Authors:  A B Kay; S Ying; V Varney; M Gaga; S R Durham; R Moqbel; A J Wardlaw; Q Hamid
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Does allergen immunotherapy alter the natural course of allergic disorders?

Authors:  X Yang
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Diagnosis and Treatment of Local Allergic Rhinitis.

Authors:  Tetsuya Terada; Ryo Kawata
Journal:  Pathogens       Date:  2022-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.